Safety of Medical Interventions in Children Versus Adults

Keywords

Exhibition, Sculpture, Architecture, Recreation, Vernacular

References

• Children Are Not Just Small Adults: The Urgent Need for High-Quality Trial Evidence in ChildrenВ. А. Льготин, Олег Геннадьевич Савичев, О. Г. Савичева — 2008
• Adverse drug reaction-related admissions in paediatrics, a prospective single-centre studyGianfranco Ciardo — 2012
• Off‐label use of medicines in paediatric inpatients at an Australian teaching hospitalEckhard Pache, Franziska Rösch — 2013
• Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.John P. A. Ioannidis, Joseph Lau — 2001
• HETEROGI: Stata module to quantify heterogeneity in a meta-analysisNicola Orsini, Matteo Bottai, Julian P. T. Higgins — 2005
• Stimulation programs for pediatric drug research – do children really benefit?Isabelle Boots, Rám N. Sukhai, R H Klein — 2007
• Uncertainty in heterogeneity estimates in meta-analysesJohn P. A. Ioannidis, Nikolaos A. Patsopoulos, Εvangelos Εvangelou — 2007
• Quantitative Synthesis in Systematic ReviewsJoseph T. F. Lau, John P.A. Ioannidis, Christopher H. Schmid — 1997
• Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.Panagiotis N. Papanikolaou, John P. A. Ioannidis — 2004
• Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementJohn P. A. Ioannidis, Stephen J.W. Evans, Peter C. Gøtzsche — 2004
• Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological OverviewSu Golder, Yoon K. Loke, Martin Bland — 2011
• A literature review on off-label drug use in childrenChiara Pandolfini, Maurizio Bonati — 2005
• Adverse events in randomized trials: neglected, restricted, distorted, and silenced.John P. A. Ioannidis — 2009
• Postmarketing surveillance--lack of vigilance, lack of trust.Phil Fontanarosa, Deborah J. Rennie, Catherine D. DeAngelis — 2004
• Adverse Drug Reactions Among Children Over a 10-Year PeriodJennifer Lê, Thủy Nguyễn, Anandi V. Law — 2006
• Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.Catherine Lloyd‐Johnsen, Frances Justice, Susan Donath — 2012
• Comparative effectiveness of medical interventions in adults versus children.Despina G. Contopoulos‐Ioannidis, Maria Baltogianni, John P. A. Ioannidis — 2010
• Pediatric information in drug product labeling.Debbie Avant — 2012
• Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.Jim Buttery, Margie Danchin, Katherine J. Lee — 2011
• Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.Adrían V. Hernández, Esteban Walker, John P. A. Ioannidis — 2008

Cited by

• Pharmacovigilance in pediatrics.Gustavo V. Barbosa‐Cánovas, Libin Ma — 2018
• Adult and paediatric cough guidelines: Ready for an overhaul?Surinder S. Birring, Joanne Kavanagh, Kefang Lai — 2015
• Clinical trials in pediatricsAnne B. Chang, Kerry-Ann O’Grady — 2014
• Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine TrialOrestis A. Panagiotou, Brian Befano, Paula González — 2015
• PRISMA harms checklist: improving harms reporting in systematic reviewsLiliane Zorzela, Yoon K. Loke, John P. A. Ioannidis — 2016
• Comparative rates of harms in randomized trials from more developed versus less developed countries may be different.Despina G. Contopoulos‐Ioannidis, Xanthippi Tseretopoulou, Megan Ancker — 2016
• Empirical evaluation of which trial characteristics are associated with treatment effect estimates.Agnès Dechartres, Ludovic Trinquart, Timor Faber — 2016
• Design and conduct of early phase drug studies in children: challenges and opportunitiesMichael Rieder, Daniel B. Hawcutt — 2016
• Insomnia From Drug Treatments: Evidence From Meta‐analyses of Randomized Trials and Concordance With Prescribing InformationAnthony G. Doufas, Orestis A. Panagiotou, P. Panousis — 2017
• Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported?—two systematic reviewsMufiza Farid‐Kapadia, Kariym C. Joachim, Chrinna Balasingham — 2017
• Do systematic reviews on pediatric topics need special methodological considerations?Mufiza Farid‐Kapadia, Lisa Askie, Lisa Hartling — 2017
• Justification de la prescription hors-AMM d’antibiotiques chez l’enfant hospitaliséC Berthod, Behrouz Kassaï, Rémy Boussageon — 2017
• The rational use of available evidence before extrapolating the benefit risk ratio from adults to childrenPerrine Janiaud — 2017
• Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited.Dario Tedesco, Mufiza Farid‐Kapadia, Martin Offringa — 2018
• Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluationBen Vandermeer, Ingeborg van der Tweel, Marijke C. Jansen‐van der Weide — 2018
• (In)-Equality in the Allocation of R&D Resources for Rare DiseasesSetti Raïs Ali, Sandy Tubeuf — 2019
• High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.—Oct. 2014Brechkerts Lieske Angruni Tukayo, Bruce Sunderland, Richard Parsons — 2020
• Co-morbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatmentMelissa Pielech, Claire E. Lunde, Sara J. Becker — 2020
• Supportive interventions for childhood cancer: An umbrella review of randomized evidence.Georgios Lavasidis, Georgios Markozannes, Kirsten Voorhies — 2022
• Off-label prescription: developing a guideline and validating an instrument to measure physicians’ and clinical pharmacists’ knowledge and attitudes toward off-label medication usePooneh Salari, Bagher Larijani, Farzaneh Zahedi — 2023

Related papers

No related papers recorded.